Showing results (281-290 of 325) with videos related to

Sort By:
Pageof 33
Nature Communications|February 10, 2025
Mitofusin 2 displays fusion-independent roles in proteostasis surveillanceMariana Joaquim, Selver Altin, Maria-Bianca Bulimaga, et al.
Neoplasia (New York, N.Y.)|July 19, 2012
Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinomaGunther Boysen, Damaris Bausch-Fluck, Claudio R Thoma, et al.
European Urology Open Science|March 6, 2023
The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort StudyStefanie Fischer, Christian Rothermundt, Odile Stalder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2009
Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysisPeter J Wild, Thomas Fuchs, Robert Stoehr, et al.
Cancers|August 4, 2019
Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial)Ivana Bratic Hench, Richard Cathomas, Luigi Costa, et al.
Urologic Oncology|November 23, 2021
Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomyNico C Grossmann, Victor M Schuettfort, Benjamin Pradere, et al.
Nature Communications|November 3, 2024
Distribution and diversity of classical deacylases in bacteriaLeonie G Graf, Carlos Moreno-Yruela, Chuan Qin, et al.
European Urology|September 10, 2014
Next-generation RNA sequencing of archival formalin-fixed paraffin-embedded urothelial bladder cancerYu Liu, Aidan P Noon, Eduardo Aguiar Cabeza, et al.
The Prostate|February 18, 2021
Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysisMarian S Wettstein, Luke A David, Clinsy Pazhepurackel, et al.
European Urology|March 1, 2016
Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of EfficacyArnoud J Templeton, Jennifer J Knox, Xun Lin, et al.
Pageof 33